{"id":"anti-il8","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Injection site reactions"},{"rate":"5-10%","effect":"Upper respiratory tract infections"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"By binding to IL-8, Anti-IL8 prevents it from interacting with its receptors, thereby inhibiting the recruitment of neutrophils and other inflammatory cells, which can help in reducing inflammation and associated symptoms.","oneSentence":"Anti-IL8 binds to interleukin-8 (IL-8), a chemokine involved in inflammation, to reduce its activity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:56:43.725Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe chronic plaque psoriasis"},{"name":"Rheumatoid arthritis"}]},"trialDetails":[{"nctId":"NCT03026140","phase":"PHASE2","title":"Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-03-29","conditions":"Colon Carcinoma","enrollment":353},{"nctId":"NCT07429773","phase":"NA","title":"Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2026-04","conditions":"Endometriosis, Chronic Pelvic Pain Syndrome","enrollment":120},{"nctId":"NCT02451982","phase":"PHASE2","title":"Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2016-03-28","conditions":"Pancreatic Cancer","enrollment":76},{"nctId":"NCT06545812","phase":"NA","title":"Immune Response During the Conservative and Minimal Invasive Treatment of Pain Caused by Lumbar Disc Herniation","status":"RECRUITING","sponsor":"Josip Juraj Strossmayer University of Osijek","startDate":"2024-09-02","conditions":"Intervertebral Disc Herniation, Back Pain, Analgesic Nephropathy","enrollment":128},{"nctId":"NCT04572451","phase":"PHASE1","title":"Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma","status":"RECRUITING","sponsor":"Yana Najjar","startDate":"2021-11-29","conditions":"Melanoma, Unresectable Solid Tumors, Neoplasms","enrollment":50},{"nctId":"NCT04347226","phase":"PHASE2","title":"Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19","status":"TERMINATED","sponsor":"Columbia University","startDate":"2020-04-16","conditions":"Solid Tumor, Sars-CoV2, Hematological Malignancy","enrollment":43},{"nctId":"NCT03689699","phase":"PHASE1, PHASE2","title":"Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mark Stein","startDate":"2018-10-11","conditions":"Prostate Cancer, Adenocarcinoma of the Prostate","enrollment":59},{"nctId":"NCT04123379","phase":"PHASE2","title":"Neoadjuvant Nivolumab with CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2020-03-05","conditions":"Non-small Cell Lung Cancer, Hepatocellular Carcinoma","enrollment":48},{"nctId":"NCT04322929","phase":"PHASE2","title":"Roflumilast in Non-CF Bronchiectasis Study (2019)","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2020-11-12","conditions":"Non-cystic Fibrosis Bronchiectasis","enrollment":42},{"nctId":"NCT04733326","phase":"PHASE1","title":"Evaluation of Post-operative Pain and Expression of IL-8 Using Ketolac or Cryoirrigation as a Final Flush in Single Visit Endodontic Treatment in Teeth With Symptomatic Irreversible Pulpitis and Apical Periodontitis.Randomized Clinical Trial.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-09-01","conditions":"Post-operative Pain","enrollment":48},{"nctId":"NCT06550752","phase":"PHASE1, PHASE2","title":"Erectile Dysfunction Treatment Using Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"COR clinic of Regenerative Medicine","startDate":"2024-08-10","conditions":"Erectile Dysfunction","enrollment":30},{"nctId":"NCT06231459","phase":"PHASE4","title":"Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","startDate":"2019-01-01","conditions":"Hypercholesterolemia, Familial","enrollment":20},{"nctId":"NCT05210894","phase":"","title":"Expanded Access for Anti-IL8","status":"NO_LONGER_AVAILABLE","sponsor":"Bristol-Myers Squibb","startDate":"","conditions":"","enrollment":""},{"nctId":"NCT04608981","phase":"PHASE4","title":"Effect of Diclofenac Potassium Versus Prednisolone on Post-endodontic Pain and Pulpal IL-8 Expression","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-03","conditions":"Symptomatic Irreversible Pulpitis","enrollment":36},{"nctId":"NCT04355416","phase":"EARLY_PHASE1","title":"Clinical and Anti-inflammatory Effect of Curcumin Oral Gel as Adjuncts in Treatment of Periodontal Pocket","status":"UNKNOWN","sponsor":"University of Baghdad","startDate":"2020-04-20","conditions":"Chronic Periodontitis","enrollment":25},{"nctId":"NCT03428334","phase":"PHASE2","title":"Roflumilast in Non-CF Bronchiectasis Study","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2018-05-10","conditions":"Non-cystic Fibrosis Bronchiectasis","enrollment":20},{"nctId":"NCT01035697","phase":"","title":"Inflammatory Cytokines Associated With Perinatal Brain Injury","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"1999-07","conditions":"Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age","enrollment":1067},{"nctId":"NCT02858297","phase":"PHASE4","title":"Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-05","conditions":"Oral Lichen Planus","enrollment":30},{"nctId":"NCT01627002","phase":"PHASE1","title":"A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401","status":"TERMINATED","sponsor":"ProtAffin Biotechnologie AG","startDate":"2012-05","conditions":"Healthy Volunteers","enrollment":49},{"nctId":"NCT00035828","phase":"PHASE2","title":"A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD","status":"COMPLETED","sponsor":"Abgenix","startDate":"2001-12","conditions":"Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Anti-IL8","genericName":"Anti-IL8","companyName":"Bristol-Myers Squibb","companyId":"bristol-myers-squibb","modality":"Biologic","firstApprovalDate":"","aiSummary":"Anti-IL8 binds to interleukin-8 (IL-8), a chemokine involved in inflammation, to reduce its activity. Used for Moderate to severe chronic plaque psoriasis, Rheumatoid arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}